Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
IPO Year:
Exchange: NYSE
Website: centene.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies |
5/30/2024 | $83.00 | Neutral | Robert W. Baird |
3/21/2024 | $92.00 → $85.00 | Overweight → Equal-Weight | Stephens |
3/6/2024 | $101.00 | Overweight | Barclays |
1/2/2024 | $82.00 → $90.00 | Equal Weight → Overweight | Wells Fargo |
8/30/2023 | $94.00 → $73.00 | Overweight → Equal-Weight | Morgan Stanley |
7/12/2023 | Outperform → Peer Perform | Wolfe Research | |
6/20/2023 | $72.00 | Neutral | UBS |
4/21/2023 | $80.00 | Overweight | Cantor Fitzgerald |
3/8/2023 | $94.00 → $79.00 | Buy → Hold | Deutsche Bank |
4 - CENTENE CORP (0001071739) (Issuer)
3 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
10-Q - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
144 - CENTENE CORP (0001071739) (Subject)
10-Q - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
DEFA14A - CENTENE CORP (0001071739) (Filer)
Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Sept. 12, 2024 /PRNewswire/ -- In response to Gov. Gavin Newsom's declared state of emergency in Los Angeles, Orange, Riverside and San Bernardino counties, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is providing special assistance to assist members affected by the Bridge and Airport fires. Health Net is committed to ensuring its members have uninterrupted access to essential prescription medications, critical Health Net information and healthcare services.
The extra benefits are in addition to regular Medicaid and CHIP coverage, helping support low-income individuals and families across the state. AUSTIN, Texas, Sept. 12, 2024 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE:CNC), announced today it invested $43.3 million in extra Medicaid and Children's Health Insurance Program (CHIP) benefits from 2019 through 2023. Known as Value-added Services, the extra benefits help provide additional support for low-income families and individuals across all 254 Texas counties.
Recognition Marks Third Consecutive Year of Centene's Annual Ranking ST. LOUIS, Sept. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it has been recognized by Fortune magazine as one of the Best Workplaces in Health Care 2024™ in the Large Company category, for the third consecutive year. "Delivering the best care for our members requires going above and beyond for each other in the workplace," said Centene Chief Executive Officer Sarah M. London. "This recognition
ST. LOUIS, Sept. 11, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it will present at the Bank of America 2024 Global Healthcare Conference in London. Centene will present on Wednesday, Sept. 18, 2024, at 5:50 am EDT /10:50 am BST. A simultaneous live audio webcast will be available at: https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2024/x1aRN0.cfm. A webcast replay will be available following the presentation on Centene's website, www.centene.com, under the Investors section. About Centene CorporationCentene Corporation, a Fortune 500 company, is a leading healthcare enterpri
Funding will Support Youth Impacted by Domestic Violence Across the State RALEIGH, N.C., Sept. 4, 2024 /PRNewswire/ -- WellCare of North Carolina (WellCare), a Medicaid health plan and a Centene Corporation (NYSE:CNC) company, announced today a $100,000 donation available to nine Family Justice Centers across North Carolina. These funds will support Camp HOPE America, a week-long overnight camp specially designed for youth impacted by domestic violence and trauma. "WellCare is committed to improving the well-being of citizens and communities across North Carolina, and this is
ST. LOUIS, Sept. 4, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Iowa-based subsidiary, Iowa Total Care, has been selected by the Iowa Department of Health and Human Services (HHS) to continue providing Medicaid managed care services under the Iowa Health Link program. The Iowa Health Link program administers Iowa Medicaid, the Iowa Health and Wellness Plan and Healthy and Well Kids in Iowa (Hawki), to eligible adults, children and pregnant women statewide. The four-year contract is expected to begin July 1, 2025, with a possible two-year extension. "Since 2019, Iowa Total Care
ST. LOUIS, Aug. 29, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it will present at the 2024 Wells Fargo Healthcare Conference. Centene will present on Wednesday, September 4 at 8:45 a.m. Eastern Daylight Time (EDT). A simultaneous live audio webcast will be available at: https://event.webcasts.com/starthere.jsp?ei=1683335&tp_key=ee7495a9c5&tp_special=8. A webcast replay will be available following the presentation on Centene's website, www.centene.com, under the Investors section. About Centene CorporationCentene Corporation, a Fortune 500 company, is a leading healthcare enterprise t
With Second Pharmacy Relocation This Year, AcariaHealth Emphasizes Commitment to Enhancing Patient Care, Empowering Employees, and Engaging Community DETROIT, Aug. 28, 2024 /PRNewswire/ -- AcariaHealth, a national specialty pharmacy focused on improving care and outcomes for patients living with complex medical conditions and a Centene company (NYSE:CNC), announced the relocation of its Homescripts pharmacy, a national leader in free goods service supporting patient medication access and adherence, to Shelby Township, Michigan. This new, nearly 33,000 square foot Detroit-area facility will provide ample space for business and pharmacy operations.
The Health Plans Have Launched a New Care Coordination Model for Their 85,000+ Members Who Lack Stable Housing LOS ANGELES, Aug. 28, 2024 /PRNewswire/ -- Today, L.A. Care Health Plan and Health Net announced a $90 million commitment over five years to ensure people who are experiencing homelessness get the preventive and coordinated, whole-person care they need, in addition to access to specialty care and other medically necessary services. L.A. Care developed two complimentary programs — the L.A. County Field Medicine Program (Field Medicine Program) and the Skid Row Care Collaborative — and in collaboration with Health Net, launched both in July. Together, the programs could assist approx
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
Jefferies downgraded Centene from Buy to Hold and set a new price target of $69.00 from $83.00 previously
Robert W. Baird initiated coverage of Centene with a rating of Neutral and set a new price target of $83.00
Stephens downgraded Centene from Overweight to Equal-Weight and set a new price target of $85.00 from $92.00 previously
Barclays initiated coverage of Centene with a rating of Overweight and set a new price target of $101.00
Wells Fargo upgraded Centene from Equal Weight to Overweight and set a new price target of $90.00 from $82.00 previously
Morgan Stanley downgraded Centene from Overweight to Equal-Weight and set a new price target of $73.00 from $94.00 previously
Wolfe Research downgraded Centene from Outperform to Peer Perform
UBS initiated coverage of Centene with a rating of Neutral and set a new price target of $72.00
Cantor Fitzgerald initiated coverage of Centene with a rating of Overweight and set a new price target of $80.00
Deutsche Bank downgraded Centene from Buy to Hold and set a new price target of $79.00 from $94.00 previously
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
Centene (NYSE:CNC) has outperformed the market over the past 20 years by 5.77% on an annualized basis producing an average annual return of 14.03%. Currently, Centene has a market capitalization of $34.60 billion. Buying $1000 In CNC: If an investor had bought $1000 of CNC stock 20 years ago, it would be worth $13,449.23 today based on a price of $64.84 for CNC at the time of writing. Centene's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed
TD Cowen analyst Gary Taylor maintains Centene (NYSE:CNC) with a Buy and lowers the price target from $91 to $80.
Jefferies analyst David Windley downgrades Centene (NYSE:CNC) from Buy to Hold and lowers the price target from $83 to $69.
Cantor Fitzgerald analyst Sarah James reiterates Centene (NYSE:CNC) with a Overweight and maintains $90 price target.
On July 22, 2024, the Centers for Medicare and Medicaid Services (CMS) published the final risk adjustment transfers for the 2023 benefit year, resulting in a final $0.0 billion receivable for Centene. As a result of the publication of the benefit year 2023 reports, the Company is providing information regarding Centene's estimated net risk adjustment payable as of March 31, 2024, as well as summarizing the second quarter and expected full year 2024 financial impact of the 2023 risk adjustment results. As of March 31, 2024, Centene had recorded a $1.3 billion 2023 risk adjustment payable, net on the Consolidated Balance Sheet.
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend. In the second quarter, UnitedHealth Group Inc (NYSE:UNH) and Elevance Health reported increasing pressure on Medicaid, creating uncertainty about when Medicaid margins will bottom out and when a potential recovery might occur. Centene Inc. (NYSE:CNC), Cigna Corp (NYSE:CI), and Molina Healthcare Inc. (NYSE:MOH) are trading at a 3x lower valuation than Elevance Health. While Elevan
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.42 ---- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $2.42, up 15% from $2.10 in the second quarter of 2023.Premium and service revenues of $36.0 billion in the second quarter of 2024.Membership increase of 34% in Marketplace, compared to the second quarter of 2023.ST. LOUIS, July 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the second quarter ended June 30, 2024. In summary, the 2024 second quarter results were as follows: Total revenues (in millions) $ 39,836 Premium and service revenues (in millions) $
ST. LOUIS, July 2, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 26, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 4980577 to expedite c
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to greater than $6.80.Premium and service revenues of $36.3 billion in the first quarter of 2024. Increases 2024 full year premium and service revenue guidance by $1.0 billion.Membership increase of 41% in Marketplace, compared to the first quarter of 2023.ST. LOUIS, April 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the first quarter ended March 31, 2024. In summary, the 2024 fir
ST. LOUIS, March 7, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 first quarter financial results at approximately 6 a.m. ET on Friday, April 26, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9229812, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors sec
-- 2023 Full Year Diluted EPS of $4.95; Adjusted Diluted EPS of $6.68 -- 2023 adjusted diluted EPS of $6.68, up over 15% from $5.78 in 2022.2023 health benefits ratio of 87.7%, consistent with 2022.Executed on capital deployment with $1.6 billion of share repurchases in 2023.Successful portfolio review execution, completing the final two international divestitures in the past two months: Circle Health and Operose Health. Increased 2024 premium and service revenues guidance by $2.5 billion.ST. LOUIS, Feb. 6, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December 31, 2023. In summary, the 2023 fou
ST. LOUIS, Jan. 23, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) issued a reminder today that it will release its 2023 fourth quarter and full year financial results at approximately 6 a.m. ET on Tuesday, February 6, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 3061147, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section. A webcast replay will be available for on-demand l
2024 adjusted diluted EPS of greater than $6.70.Board authorizes $4.0 billion increase to stock repurchase program.Reaffirms 2023 adjusted diluted EPS guidance of at least $6.60.ST. LOUIS, Dec. 12, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") today will host its investor day to outline its 2024 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value. "We continue to execute against our strategic plan, positioning Centene to deliver strong, long-term earnings growth and create meaningful shareholder value. Looking to the year ahead, we see the opportunity to provide access to high-quality health car
ST. LOUIS, Oct. 3, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise that is committed to helping people live healthier lives, announced that it will release its 2023 third quarter financial results at approximately 6 a.m. EDT on Tuesday, October 24, 2023, and will host a conference call afterwards at approximately 8:30 a.m. EDT to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 3130388, to expedite caller registration; or via a live, audio webcast on the Company's website at www.
-- Diluted EPS of $1.92; Adjusted Diluted EPS of $2.10 -- -- Increases 2023 Full Year Guidance -- Adjusted diluted EPS of $2.10, up over 18% from $1.77 in the second quarter of 2022.Premium and service revenues of $34.8 billion in the second quarter of 2023.Medicaid redeterminations progressing as expected.Increases 2023 full year adjusted diluted EPS guidance by $0.05 to at least $6.45; reiterates 2024 adjusted diluted EPS floor of greater than $6.60.ST. LOUIS, July 28, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the second quarter ended June 30, 2023. In summary, the 2023 second quarter results were as follows: Total revenue
-- Diluted EPS of $2.04; Adjusted Diluted EPS of $2.11 -- -- Increases 2023 Full Year Guidance and Updates 2024 Target -- Increased 2023 full year Adjusted EPS guidance to at least $6.40 driven by strong performance in its market leading Medicaid and Marketplace businesses.Premium and service revenues of $35.0 billion in the first quarter of 2023.Health benefits ratio of 87.0% in the first quarter of 2023, driven by continued disciplined Marketplace pricing and favorable Medicare performance.Updates the 2024 Adjusted EPS target to greater than $6.60, reflecting an updated view of Medicaid redeterminations, Medicare bid strategy, and business investments, to be further discussed on the earnin
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene's core services operations ST. LOUIS, Jan. 22, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced two appointments. Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare. Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola. Carson succeeds Richard Fisher, who has
PA Health & Wellness Safe & Sound Program to provide assistance with critical home repairs in Greater Harrisburg area HARRISBURG, Pa., Dec. 11, 2023 /PRNewswire/ -- PA Health & Wellness (PHW), a wholly owned subsidiary of Centene Corporation (NYSE:CNC), and Centene Foundation, the philanthropic arm of Centene Corporation, today announced its new partnership with Habitat for Humanity of the Greater Harrisburg Area to provide critical home repairs to area homeowners as part of the organization's Critical Home Repair program. The new program – PHW Safe & Sound – will cover the cost of eligible interior and exterior structural, electrical, plumbing, HVAC and other critical home repairs so that
Proctor brings more than 20 years of healthcare industry experience and proven leadership to Nebraska Total Care OMAHA, Neb., Nov. 16, 2023 /PRNewswire/ -- Nebraska Total Care, a leading provider of government-sponsored healthcare plans in Nebraska and wholly owned subsidiary of Centene Corporation (NYSE:CNC), announced today that Adam Proctor has been appointed as Plan President and Chief Executive Officer, effective November 19, 2023. Proctor replaces Heath Phillips, who was appointed to President and CEO overseeing Centene's Medicaid, Medicare and Marketplace offerings in Tennessee including Rhythm Health, Wellcare of Tennessee and Ambetter of Tennessee.
ST. LOUIS, Nov. 15, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today announced the appointment of Susan Smith as its Chief Operating Officer (COO), effective January 1, 2024. As COO, Ms. Smith will report to Centene President Ken Fasola and will be responsible for core business operations, population health, the enterprise transformation office, provider experience and quality. She has worked at Centene since June 2023. Ms. Smith brings nearly two decades of expertise in
Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J
TORONTO, April 5, 2023 /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX:CNIKF) is pleased to announce the appointment of Cutfield Freeman & Co. ("Cutfield Freeman") as project debt advisors and changes to the Canada Nickel Board of Directors (the "Board"). Mark Selby, Chair and CEO said, "I am very pleased that we have engaged Cutfield Freeman, a leading global mining advisory firm, as project debt advisors. Cutfield Freeman, in conjunction with our previously appointed equity advisors, Deutsche Bank and Scotiabank, will assist t
ST. LOUIS, March 27, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today the appointment of Tanya McNally to Senior Vice President and Chief People Officer of Centene. As the Chief People Officer, Ms. McNally will lead the Human Resources (HR) function and drive strategies to optimize employee and business success. She will continue to grow best-in-class talent management programs focused on developing and retaining Centene's more than 74,000 purpose-driven employees. "I look forward to Tanya's leadership and continued success in promoting talent growth and inn
Ken Fasola named President of Centene Jim Murray named Chief Operating Officer Brent Layton becomes Senior Advisor to the CEO Dave Thomas becomes Chief Executive Officer of Markets and Medicaid Additionally, Company appoints Alice H. Chen, MD, MPH as Chief Health Officer and Brian LeClaire, MBA, PhD, as Chief Information Officer ST. LOUIS, Dec. 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today leadership changes and senior management appointments to position the Company for its next stage of growth. "With these appointments, Centene is aligning the outstanding talent within our senior executive team with the Company's value creation mission and long-term strategy fo